Saturday, June 27, 2026

#antibody-drug conjugates

4 articles

FDA H2 2026 Oncology Docket Packs Four Major Decisions Into One Catalyst Window

Healthcare Sector

FDA H2 2026 Oncology Docket Packs Four Major Decisions Into One Catalyst Window

Salvado•Jun 17, 2026

Oncology Biotech Stocks Face Critical Q3-Q4 2026 FDA Decisions Clustering Around Novel Drug Mechanisms

Biotech Equities

Oncology Biotech Stocks Face Critical Q3-Q4 2026 FDA Decisions Clustering Around Novel Drug Mechanisms

Salvado•Apr 18, 2026

FDA Priority Review for B7-H3 Antibody Drug Conjugate Accelerates Biotech Market Activity

Healthcare Sector Trading

FDA Priority Review for B7-H3 Antibody Drug Conjugate Accelerates Biotech Market Activity

Salvado•Apr 16, 2026

Precision Oncology Stocks Poised for Catalyst-Rich Quarter as Multiple Biotech Firms Race Toward Regulatory Milestones

Biotech & Pharma Stocks

Precision Oncology Stocks Poised for Catalyst-Rich Quarter as Multiple Biotech Firms Race Toward Regulatory Milestones

ViaNews Editorial Team (Markets)•Feb 15, 2026